The First FDA-Approved Alzheimer’s Blood Test: What You Need to Know
Fujirebio’s new blood test for Alzheimer’s biomarkers is the first to receive FDA approval, opening the door to Medicare coverage. Here’s what it can…
Fujirebio’s new blood test for Alzheimer’s biomarkers is the first to receive FDA approval, opening the door to Medicare coverage. Here’s what it can…
Common viral infections may make the brain more susceptible to dementia and other neurological diseases. For instance, the Epstein-Barr virus — which causes mononucleosis…
More than a decade ago, Alzheimer’s vaccines appeared in clinical trials — but failed. Now several companies are gearing up to test the next…
A person who struggles with tasks they’ve been doing for years or asks the same question over and over again may be showing the…
People with Down syndrome have a 9/10 chance of developing early-onset Alzheimer’s — a reality tied to genetics. This genetic condition also makes this…
Why are researchers still fumbling in the quest to cure what is arguably one of the most important diseases confronting humankind — Alzheimer’s disease?…
Editor’s note: This is a mouse study. Studies in mice rarely translate to humans. An inert and unreactive gas may not seem like an…